The drug also made the animals less likely to pursue food in stressful environments and reduced obsessive food-seeking in tests designed to measure craving. SKNY-1 significantly reduced the desire to ...

The drug also made the animals less likely to pursue food in stressful ... "These results highlight SKNY-1's potential to address both obesity and nicotine addiction through unique and safe pathways." ...

Utah Gov. Spencer Cox, Utah Attorney General Derek Brown, and the Utah Department of Commerce’s Margaret Busse filed a lawsuit against Snap, Inc.The lawsuit all ...

Researchers at the University of Southern California found the popularity of nicotine pouches is soaring, especially among ...

Some people with long COVID are turning to an unlikely remedy: nicotine gum and patches. Though typically used to quit ...

Achieve Life Sciences, Inc. has submitted a New Drug Application (NDA) to the U.S. FDA for cytisinicline, which, if approved, would be the first new pharmacotherapy for nicotine dependence in 20 ...

And over the past several years, they’ve skyrocketed in popularity.

Some pediatric doctors in the metro Atlanta area say they’re alarmed by the soaring use of nicotine pouches by teens. The ...

To be very clear: Anyone taking nicotine to treat brain fog (like me) is still very much experimenting. There are no protocols or prescribed doses approved by the Food and Drug Administration.

Achieve Life Sciences is partnering with marketing company Omnicom to lead Achieve's commercial launch of a potential new treatment for nicotine dependence in the U.S. The pharmaceutical company on ...

The tax on pouches, including brands such as Zyn, is expected to generate $12 million per year for the state. But the company ...

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved ...